8 February 2022
Sue Trinh, Head of Macro Strategy, Asia
Asia isn’t immune to emerging global macro headwinds. The region’s overall growth picture this year is likely to be mixed; however, there are good reasons to believe that inflation isn’t likely to dent the continent’s prospects.
It would be disingenuous to paint a rosy picture of the region’s growth prospects— important challenges remain. It’s undeniable that economies in the region have a long way to go to recoup output that’s been lost due to disruptions brought about by the pandemic. In our view, the biggest concern remains weak consumer demand, which will be exposed by the looming downturn in export growth.
The upshot, however, is that policymakers in the region can afford to be patient when it comes to monetary policy normalization. While prices are expected to tick up further, large output gaps—the difference between an economy’s actual output and its potential output—should help keep underlying price pressures in check. As such, we believe Asia will escape the worst of the global inflationary shock, particular versus other emerging-market (EM) economies, even if inflationary pressures heighten as a result of ongoing global supply bottlenecks.
Broadly speaking, Asia’s milder inflation outlook comes down to one simple factor— trade surpluses. Economies in the region were able to maximize export production through much of the past two years. At the same time, the surge in pent-up demand in Asia after the reopening wasn’t as strong relative to other regions, particularly when compared with other EM economies.
Chart 1: EM economies: aggregate trade balances
Chart 2: Household consumption growth
Much smaller-ramp up in Asia vs. other EM in past year
Source: Macrobond, Manulife Investment Management, as of January 7, 2022. EM refers to emerging markets. YoY refers to year over year.
One other set of data also supports our view that inflationary pressure in Asia is likely to be more tamed: long-distance freight rates. The rise in intra-Asia shipping costs has been much more muted in comparison with other regions, thanks to excess manufacturing supply and relatively weaker consumer spending. An important takeaway here is what this means in regard to monetary policy: For the region as a whole, we expect to see policy normalization take place at a much slower pace and at a lower magnitude relative to previous cycles and other EM economies.
Chart 3: Shipping costs from Asia have risen dramatically since the pandemic
Source: Bloomberg, Macrobond, Manulife Investment Management, as of January 13, 2022.
Taiwan and Vietnam
These two economies are already growing above their long-term trend GDP levels, and consensus forecasts point toward a Goldilocks regime of accelerating growth and decelerating inflation this year.
In Taiwan’s case, GDP is likely to be boosted by a consumption recovery and steady support from investment. Continued global demand for semiconductors amid tight supply should help support Taiwan exports even as global consumption patterns normalize.
Meanwhile, economic activity in Vietnam has resumed much faster than anticipated following extensive factory disruptions in Q3. Fiscal support also continues unabated. Vietnam’s parliament hasa stimulus package worth ~5.5% of the country’s GDP, with a focus on assisting virus-hit businesses and workers. Notably, around half the package is focused on increased infrastructure spending for 2022/2023. In our view, foreign direct investment into Vietnam should underpin GDP for some time.
Singapore and Malaysia
These two economies may be starting the year at below-trend GDP, but we think they have strong potential to recoup lost output. In Singapore, the pace at which vaccination/booster shots are administered has enabled a calibrated reopening; a broad-based recovery therefore seems feasible with an improving labor market. In Malaysia, an accelerated vaccination rate and higher government spending ahead of the upcoming election—widely expected to take place in the second half of the year— should support domestic demand.
Personal consumption, particularly of in-person services, has been since the state of emergency was lifted last September. Nonetheless, prices should stay benign, and we believe any effort from the Bank of Japan to withdraw liquidity will lag its developed-market peers.
Overall, the macro picture in Asia is likely to be mixed; however, the operating environment is likely to be more favorable for select economies in the region. Crucially, the relatively muted rise in consumer demand and existing excess capacity mean that inflationary pressure on the continent isn’t likely to be as acute as in other parts of the world—implying that the likelihood of a mad dash to normalize monetary policy is much lower.
China rolls out measures to support economic growth
We believe that the latest supportive measures reiterate China’s stance on economic stability and see opportunities in China and Hong Kong equities that could benefit from these policy actions.
Sri Lanka’s difficult road ahead
Sri Lanka's imminent default holds lessons for investors and underscores the value of a sustainable investing framework.
Monetary tightening amid heightened uncertainty: implications for emerging markets
The March FOMC meeting told us that the Fed is still prepared to proceed with rate hikes to fight near-term inflation. Do we need to worry about another Fed tantrum in emerging markets? From a macro perspective, there are two ways to answer this question.
The information provided on this website is for informational purposes only and is intended solely for use by Singapore residents and is not intended for distribution to, or use by, any person or entity in the United States, or any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G) and/or its affiliates (collectively hereafter "Manulife") or any of Manulife's products or services to any registration requirement within such jurisdiction or country. Nothing on this website shall be construed as financial advice or an offer, invitation, solicitation or recommendation by or on behalf of Manulife to any person to buy or sell any Fund and is no indication of trading intent in any Fund managed by Manulife. None of the information or analyses presented are intended to form the basis for any investment decision, and no specific recommendations are intended.
Investments in any Fund are not deposits in, guaranteed or insured by Manulife and involve risks. The value of units in any Fund and any income accruing to it may fall or rise. Past performance of the Fund is not necessarily indicative of future performance. The Fund may use or invest in financial derivative instruments. Investors should read the prospectus and seek advice from a financial adviser, before deciding whether to subscribe for or purchase units in any Fund. In the event an investor chooses not to seek advice from a financial adviser, he should consider whether the Fund(s) is/are suitable for him. Copies of the prospectus and the product highlights sheets can be obtained from Manulife or its distributors, for further details (including the risk factors) and charges.
The Manager shall have the absolute discretion to determine whether a distribution is to be made in respect of any Fund as well as the rate and frequency of distributions to be made. The intention of the Manager to make the distribution and the distribution yield for the Fund is not guaranteed, and the Manager may review the distribution policy depending on prevailing market conditions. Distributions may be made out of income, net capital gains and/or capital. Past distribution yields and payments are not necessarily indicative of future distribution yields and payments. Any payment of distributions by the Fund may result in an immediate decrease in the net asset value per unit.
All advertisements or publications provided on this website have not been reviewed by the Monetary Authority of Singapore.
Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G)